In vitro and in vivo Signaling Mechanisms during Endothelial Tube Formation

内皮管形成过程中的体外和体内信号传导机制

基本信息

  • 批准号:
    8536319
  • 负责人:
  • 金额:
    $ 26.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our long-term goal is to understand the cellular mechanisms that regulate vesicle trafficking during endothelial tube formation. Our objective is to define critical genes involved in the formation of the apical membrane and the coordination between vesicle trafficking and the remodeling of cellular junctions during endothelial tube formation. Our principle hypothesis is that endothelial tube formation is tightly coupled to adherence and tight junction remodeling and that these apical junctions direct vesicle trafficking during formation of the apical membrane in vitro and in vivo. In support of this hypothesis, we have identified a number of proteins involved in cellular junctions and vesicle trafficking and demonstrated that these genes are required for endothelial tube formation in human umbilical vein endothelial cells in culture and during embryonic angiogenesis in zebrafish. We have chosen to work with zebrafish because of the combined advantages of a well-defined genome that relates to the human genome, the ability to efficiently knockdown genes and produce transgenic animals, and the optical clarity of the embryo that allows a detailed examination of tube formation on the single cell level in vivo. Complementary to this approach, we follow the same processes biochemically in vitro. We provide preliminary evidence suggesting a close coupling of vesicle trafficking and apical junctional remodeling. Our team has extensive experience with the generation of transgenic zebrafish using transposon-mediated transgenesis techniques, the injection of antisense morpholino oligonucleotides, and the examination of protein-protein interactions in vitro. We have taken an innovative and comparative approach to this problem by combining in vitro and in vivo experiments. We use transgenic zebrafish and human endothelial cells that express fluorescently tagged proteins to answer fundamental cell biological questions regarding endothelial tube formation. At the end of the granting period, we will have defined novel mechanisms that function during endothelial tube formation. This understanding is critical to the development of new therapeutic strategies to modulate of endothelial tube formation and diameter. This ability would have direct implications for the treatment of heart disease, ischemia, and cancer.
描述(由申请人提供):我们的长期目标是了解内皮管形成过程中调节囊泡运输的细胞机制。我们的目标是确定参与顶膜形成的关键基因,以及内皮管形成过程中囊泡运输和细胞连接重塑之间的协调。我们的主要假设是内皮管的形成与粘附和紧密连接的重塑紧密耦合,这些顶端连接在体外和体内的顶端膜形成过程中指导囊泡运输。为了支持这一假设,我们已经确定了一些参与细胞连接和囊泡运输的蛋白质,并证明这些基因是培养的人脐静脉内皮细胞和斑马鱼胚胎血管生成过程中内皮管形成所必需的。我们选择用斑马鱼进行研究,是因为它具有与人类基因组相关的定义明确的基因组、有效敲除基因和产生转基因动物的能力,以及胚胎的光学清晰度,可以在体内单细胞水平上详细检查管的形成。作为这一方法的补充,我们在体外遵循同样的生化过程。我们提供的初步证据表明,囊泡运输和根尖交界处重塑密切相关。我们的团队在使用转座子介导的转基因技术,注射反义morpholino寡核苷酸,以及在体外检测蛋白质-蛋白质相互作用方面拥有丰富的经验。我们通过结合体外和体内实验,采取了创新和比较的方法来解决这个问题。我们使用表达荧光标记蛋白的转基因斑马鱼和人内皮细胞来回答有关内皮管形成的基本细胞生物学问题。在批准期结束时,我们将确定内皮管形成过程中起作用的新机制。这种理解对于开发新的治疗策略来调节内皮管的形成和直径是至关重要的。这种能力将对心脏病、缺血和癌症的治疗产生直接影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeffrey J Essner其他文献

Jeffrey J Essner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeffrey J Essner', 18)}}的其他基金

Fluorescence stereomicroscope imaging systems
荧光立体显微镜成像系统
  • 批准号:
    10601232
  • 财政年份:
    2016
  • 资助金额:
    $ 26.12万
  • 项目类别:
Development of tools for site-directed analysis of gene function
基因功能定点分析工具的开发
  • 批准号:
    9457505
  • 财政年份:
    2016
  • 资助金额:
    $ 26.12万
  • 项目类别:
In vitro and in vivo Signaling Mechanisms during Endothelial Tube Formation
内皮管形成过程中的体外和体内信号传导机制
  • 批准号:
    8325522
  • 财政年份:
    2011
  • 资助金额:
    $ 26.12万
  • 项目类别:
In vitro and in vivo Signaling Mechanisms during Endothelial Tube Formation
内皮管形成过程中的体外和体内信号传导机制
  • 批准号:
    8194585
  • 财政年份:
    2011
  • 资助金额:
    $ 26.12万
  • 项目类别:
In vitro and in vivo Signaling Mechanisms during Endothelial Tube Formation
内皮管形成过程中的体外和体内信号传导机制
  • 批准号:
    8725185
  • 财政年份:
    2011
  • 资助金额:
    $ 26.12万
  • 项目类别:
Use of RecA to Promote Gene Targeting
使用 RecA 促进基因靶向
  • 批准号:
    7786194
  • 财政年份:
    2009
  • 资助金额:
    $ 26.12万
  • 项目类别:
ANGIOGENESIS TARGETS FOR THERAPEUTIC DEVELOPMENT
治疗开发的血管生成目标
  • 批准号:
    6790744
  • 财政年份:
    2004
  • 资助金额:
    $ 26.12万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 26.12万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 26.12万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 26.12万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 26.12万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 26.12万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 26.12万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 26.12万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 26.12万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 26.12万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 26.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了